日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/23 | 1,880 | 1,889 | 1,880 | 1,881 | -11 | -0.6% | 1,400 |
| 2022/08/22 | 1,873 | 1,894 | 1,873 | 1,892 | +2 | +0.1% | 1,800 |
| 2022/08/19 | 1,872 | 1,890 | 1,872 | 1,890 | +18 | +1% | 4,500 |
| 2022/08/18 | 1,870 | 1,883 | 1,870 | 1,872 | -11 | -0.6% | 2,300 |
| 2022/08/17 | 1,863 | 1,883 | 1,863 | 1,883 | +13 | +0.7% | 5,100 |
| 2022/08/16 | 1,862 | 1,877 | 1,859 | 1,870 | +4 | +0.2% | 4,500 |
| 2022/08/15 | 1,868 | 1,870 | 1,864 | 1,866 | -2 | -0.1% | 1,700 |
| 2022/08/12 | 1,874 | 1,874 | 1,860 | 1,868 | +2 | +0.1% | 3,300 |
| 2022/08/10 | 1,855 | 1,866 | 1,854 | 1,866 | +12 | +0.6% | 1,500 |
| 2022/08/09 | 1,855 | 1,855 | 1,854 | 1,854 | -1 | -0.1% | 1,200 |
| 2022/08/08 | 1,854 | 1,867 | 1,854 | 1,855 | -5 | -0.3% | 3,000 |
| 2022/08/05 | 1,858 | 1,868 | 1,858 | 1,860 | +2 | +0.1% | 1,700 |
| 2022/08/04 | 1,873 | 1,873 | 1,853 | 1,858 | -2 | -0.1% | 8,600 |
| 2022/08/03 | 1,880 | 1,882 | 1,860 | 1,860 | -7 | -0.4% | 5,000 |
| 2022/08/02 | 1,880 | 1,880 | 1,866 | 1,867 | -13 | -0.7% | 7,900 |
| 2022/08/01 | 1,886 | 1,886 | 1,865 | 1,880 | +18 | +1% | 8,900 |
| 2022/07/29 | 1,868 | 1,874 | 1,862 | 1,862 | -5 | -0.3% | 4,700 |
| 2022/07/28 | 1,875 | 1,885 | 1,867 | 1,867 | -1 | -0.1% | 3,700 |
| 2022/07/27 | 1,861 | 1,880 | 1,861 | 1,868 | -25 | -1.3% | 12,400 |
| 2022/07/26 | 1,885 | 1,894 | 1,880 | 1,893 | +11 | +0.6% | 3,500 |
| 2022/07/25 | 1,878 | 1,886 | 1,870 | 1,882 | +12 | +0.6% | 5,400 |
| 2022/07/22 | 1,875 | 1,878 | 1,868 | 1,870 | -5 | -0.3% | 7,300 |
| 2022/07/21 | 1,870 | 1,878 | 1,867 | 1,875 | -2 | -0.1% | 2,100 |
| 2022/07/20 | 1,872 | 1,880 | 1,871 | 1,877 | +9 | +0.5% | 2,000 |
| 2022/07/19 | 1,887 | 1,887 | 1,868 | 1,868 | -6 | -0.3% | 1,500 |
| 2022/07/15 | 1,890 | 1,890 | 1,874 | 1,874 | -9 | -0.5% | 1,300 |
| 2022/07/14 | 1,872 | 1,891 | 1,872 | 1,883 | +13 | +0.7% | 1,500 |
| 2022/07/13 | 1,875 | 1,889 | 1,870 | 1,870 | -5 | -0.3% | 2,500 |
| 2022/07/12 | 1,871 | 1,894 | 1,871 | 1,875 | -5 | -0.3% | 2,600 |
| 2022/07/11 | 1,896 | 1,898 | 1,865 | 1,880 | +15 | +0.8% | 5,900 |
| 2022/07/08 | 1,896 | 1,896 | 1,860 | 1,865 | -1 | -0.1% | 11,300 |
| 2022/07/07 | 1,868 | 1,878 | 1,866 | 1,866 | ±0 | ±0% | 1,700 |
| 2022/07/06 | 1,869 | 1,876 | 1,866 | 1,866 | -7 | -0.4% | 2,700 |
| 2022/07/05 | 1,883 | 1,896 | 1,866 | 1,873 | -9 | -0.5% | 4,800 |
| 2022/07/04 | 1,897 | 1,897 | 1,874 | 1,882 | +8 | +0.4% | 1,700 |
| 2022/07/01 | 1,874 | 1,875 | 1,874 | 1,874 | ±0 | ±0% | 2,100 |
| 2022/06/30 | 1,898 | 1,898 | 1,874 | 1,874 | -9 | -0.5% | 4,400 |
| 2022/06/29 | 1,915 | 1,915 | 1,883 | 1,883 | -32 | -1.7% | 16,000 |
| 2022/06/28 | 1,910 | 1,930 | 1,902 | 1,915 | +6 | +0.3% | 5,500 |
| 2022/06/27 | 1,950 | 1,950 | 1,905 | 1,909 | +5 | +0.3% | 8,100 |
| 2022/06/24 | 2,011 | 2,011 | 1,864 | 1,904 | -96 | -4.8% | 38,000 |
| 2022/06/23 | 1,903 | 2,170 | 1,898 | 2,000 | +129 | +6.9% | 81,200 |
| 2022/06/22 | 1,878 | 1,881 | 1,871 | 1,871 | -7 | -0.4% | 2,800 |
| 2022/06/21 | 1,870 | 1,894 | 1,861 | 1,878 | +8 | +0.4% | 5,000 |
| 2022/06/20 | 1,876 | 1,876 | 1,870 | 1,870 | -6 | -0.3% | 1,300 |
| 2022/06/17 | 1,888 | 1,891 | 1,876 | 1,876 | -19 | -1% | 4,500 |
| 2022/06/16 | 1,899 | 1,900 | 1,890 | 1,895 | +6 | +0.3% | 1,700 |
| 2022/06/15 | 1,901 | 1,901 | 1,889 | 1,889 | -7 | -0.4% | 3,100 |
| 2022/06/14 | 1,903 | 1,919 | 1,896 | 1,896 | -7 | -0.4% | 1,800 |
| 2022/06/13 | 1,906 | 1,920 | 1,900 | 1,903 | -7 | -0.4% | 3,400 |
651～
700
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 144,100円 | +2.5% | - | 3.47% | 86.65倍 | 0.28倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ノイルイミューン | 14,500円 | -28.6% | - | 0.00% | - | 1.33倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| キッズバイオ | 14,500円 | - | - | 0.00% | - | 8.06倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| クリングル | 87,900円 | +240.0% | - | 0.00% | - | 2.88倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| モダリス | 8,100円 | - | - | 0.00% | - | 1.69倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
市場注目の銘柄
チャート関連のコラム
